RUBIN’S REFLECTIONS

Follow on Twitter @IBDMD

Message to Dr. Rubin’s Patients Related to COVID-19 Boosters

Aug 13, 2021

Dear Friends and Patients, I hope this message finds you well. Please excuse the group nature of this message, but I did want to reach out with the latest update about COVID-19, and vaccinations. If you want to skip right to the booster info, scroll down to #5 below....

Tweetorial to Provide Updates on COVID-19 for Patients with IBD

Jul 30, 2021

View Twitter Thread To watch me deliver the full lecture and view the presentation, click here. I recently gave a lecture about COVID-19 and vaccination with specific information for patients with IBD. This lecture was recorded on July 21st, before the CDC issued...

Tweetorial to Clarify the NYT Article From 15 April and Further Explain/Clarify the UK CLARITY IBD Study

Apr 18, 2021

Tweetorial to Clarify the NYT Article From 15 April and Further Explain/Clarify the UK CLARITY IBD Study David T. Rubin View Twitter Thread I've previously commented about the CLARITY IBD Study (Kennedy, et al). paper in this forum, but it bears repeating and further...

SARS Vaccine and IBD Tweetorial Summary from December 1

Dec 5, 2020

SARS Vaccine and IBD Tweetorial Summary from December 1 David T. Rubin View Twitter Thread Here are my thoughts and a few updates about SARS-CoV-2 vaccines, and also about important implications for our IBD patients. Development of multiple SARS-CoV-2 vaccines in the...

Approach to Management and Interpretation of Testing Results in Patients with IBD, with Particular Attention to Restarting Therapy

Apr 21, 2020

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine As testing for SARS-CoV-2 is expanded and serologic antibody testing becomes available, we are faced with a number of different clinical scenarios. I have outlined the different situations...

Three waves of Illness from the COVID-19 Pandemic

Apr 1, 2020

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine I've been thinking about what comes next, and how can we get ahead of this, and propose the following for consideration. I believe that there will be three waves of illness from the...

Newly Discovered Vascular Barrier in the Brain May Explain IBD-Related Anxiety, Depression

by nmgarcia | November 9, 2021 | In the Press | 0 Comments

A newly discovered vascular brain barrier that blocks the passage of inflammatory molecules triggered by gut bacteria may be why patients with inflammatory bowel disease (IBD) are at increased risk for certain mental health disorders, including anxiety and depression,...

Dr. David T. Rubin on Transabdominal Ultrasound for IBD: Lessons from STARDUST Substudy on Ustekinumab

by David Rubin | January 19, 2024 | In the Press | 0 Comments

Intestinal ultrasound has become a useful tool in assessing disease progression and pathophysiology of inflammatory bowel disease (IBD). It’s an approach to visualizing the intestines using a transabdominal ultrasound probe to provide real-time information. But could...

SARS Vaccine and IBD Tweetorial Summary from December 1

by David Rubin | December 5, 2020 | Coronavirus, Rubin's Reflections | 0 Comments

Lee Matricaria’s Story

by David Rubin | February 12, 2021 | In the Press | 0 Comments

How should we support the healthcare worker with IBD who is receiving immune therapies during the SARS-CoV-2 pandemic?

by dtrubin | March 21, 2020 | Coronavirus, Rubin's Reflections | 0 Comments

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine (Posted to IBD-circle.within3.com on March 21, 2020) Dear Colleagues, I have been fielding lots of questions about whether our IBD patients on immune therapies should stay home from work....

Dr. Rubin summarizes IBD treatment options on Medscape ReCAP

by dtrubin | July 29, 2020 | In the Press | 0 Comments

Dr. Rubin discusses the three classes of biologic therapies approved for IBD. These therapies, albeit revolutionary for patient care are limited by clearance issues, need for dose escalation, and loss of response. The arrival of small molecule therapies, such as...

Improvements in Testing for SARS-CoV-2 and COVID-19 and How They Will Transform What we are Doing

by dtrubin | April 1, 2020 | Coronavirus, Rubin's Reflections | 0 Comments

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine Here are some improvements in testing for SARS-COV-2 and COVID-19 and how I think they will transform what we are doing: 1. Faster Viral Tests for SARS-CoV-2. Several companies have adapted...

Should You Scale Back on Your UC Treatment?

by zfine | May 28, 2025 | In the Press | 0 Comments

A provocative new paper proposes that less could be more for some people when it comes to drug therapy for IBD. https://www.healthcentral.com/news/ulcerative-colitis/should-you-scale-back-on-your-uc-treatment

Dr. David T. Rubin Guest-Hosts IBD Drive Time

by David Rubin | June 7, 2023 | In the Press | 0 Comments

Take a listen to Dr. Rubin discuss the impact of inflammatory bowel disease on sexual function with University of Chicago's GI psychologist, Dr. Alyse Bedell, and pelvic floor physical therapist, Sarah Macaraeg.

Dr. David T. Rubin Shares Expert Advice on How to Get Your Work Published

by David Rubin | January 28, 2022 | In the Press | 0 Comments

Originally presented at the Crohn’s and Colitis Congress with colleagues Fabio Cominelli, MD, PhD, of Case Western Reserve University, and Siddharth Singh, MD, of the University of California San Diego, Rubin highlighted the importance of choosing the most appropriate...